Holdings

Rock Springs Capital Management LP

As of Sep 30, 2026, Rock Springs Capital Management LP reported 102 positions worth US$1.78B. Largest: Revolution Medicines, Inc., Travere Therapeutics, Inc. and Eli Lilly and Company. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Revolution Medicines, Inc.869KUS$178M−236KSep 30, 2026
Travere Therapeutics, Inc.2.2MUS$130M+25,016Sep 30, 2026
Eli Lilly and Company98,700US$114Mno changeSep 30, 2026
Madrigal Pharmaceuticals, Inc.177KUS$89.3M+2,250Sep 30, 2026
Mirum Pharmaceuticals, Inc.780KUS$66.7M−18,355Sep 30, 2026
Rhythm Pharmaceuticals, Inc.693KUS$65.9Mno changeSep 30, 2026
Kymera Therapeutics, Inc.410KUS$45.8M−43,525Sep 30, 2026
Insmed Incorporated365KUS$41.7M+3,100Sep 30, 2026
UnitedHealth Group Incorporated92,250US$33.9M+28,500Sep 30, 2026
Scholar Rock Holding Corporation683KUS$33M−32,798Sep 30, 2026